tirzepatide weight loss injections framingham vs. Semaglutide: Which Medication Is Right for You? Tirzepatide Weight Loss Injections |

Regular Monitoring: Consider scheduling check-ins specifically to assess: Rate of weight loss Dietary intake adequacy Signs of nutritional deficiency Hair health changes When to See a Dermatologist While most GLP-1-related hair loss is straightforward telogen effluvium that resolves on its own, some situations warrant specialized evaluation: See a Board-Certified Dermatologist If: Hair loss is severe or worsening despite weight stabilization You notice bald patches or patchy hair loss (may indicate alopecia areata) Hair loss persists beyond 6 months after weight stabilizes You have scalp symptoms (itching, burning, scaling, pain) You notice unusual patterns of loss (frontal hairline recession, crown thinning) You have a personal or family history of autoimmune conditions What a Dermatologist Can Do: Perform scalp examination and possibly biopsy to confirm diagnosis Rule out other conditions (thyroid disease, autoimmune alopecia, infections) Prescribe prescription treatments if appropriate Order comprehensive blood work to identify deficiencies Provide PRP or other advanced treatments Monitor progress and adjust treatment plan Realistic Expectations: What to Hope For If youre experiencing GLP-1-related hair loss, heres what realistic recovery looks like: Timeline: Months 0-3: Active shedding period

doi: 10.1007/s00125-012-2459-7

PlexusDx is cash-pay, no membership, no commitment, and uses licensed U.S

You should consider reaching out (virtually or in person) if you have: Not had a bowel movement for more than 3 to 4 days Severe abdominal pain or distention Blood in your stool Constipation that significantly impacts quality of life Constipation that doesn't improve with your usual self-management strategies How pelvic floor physical therapy can help Pelvic floor physical therapy can be a very helpful tool when managing GLP-1-related constipation

GargIUwakweCLeRLuESCuiYWaiKMet al

The medication, which is part of a drug class glucagon-like peptide 1 (GLP-1), can reduce the risk of a stroke, heart attack, or death in adults who have type 2 diabetes, along with heart and blood vessel disease